DO TOCOLYTIC AGENTS STOP PRETERM LABOR - A CRITICAL AND COMPREHENSIVE REVIEW OF EFFICACY AND SAFETY

被引:202
作者
HIGBY, K
XENAKIS, EMJ
PAUERSTEIN, CJ
HARBERT, GM
JONES, H
MERKATZ, IR
CREASY
WOODS, J
CEFALO, RC
GIBBS, RS
SCOTT, S
QUEENAN, JT
KIRSCHBAUM
NELSON, K
机构
[1] Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, TX
关键词
PREMATURE LABOR; TOCOLYTICS; MAGNESIUM SULFATE; BETA-ADRENERGIC RECEPTOR AGONISTS; CALCIUM CHANNEL BLOCKERS;
D O I
10.1016/0002-9378(93)90376-T
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our aim was to determine the efficacy and safety of tocolytic agents currently used to treat premature labor. STUDY DESIGN: We carried out a comprehensive review of tocolytic agents in the treatment Of premature labor. Three hundred twenty-eight studies published between 1933 and 1992 were analyzed. RESULTS: An analysis of randomized, placebo-controlled, clinical trials showed that magnesium sulfate is not better than placebo in the treatment of premature labor. Beta-Adrenergic receptor agonists effectively stop premature labor for only 24 to 48 hours. Calcium channel blockers and oxytocin antagonists inhibit uterine contractions, but their role in stopping labor is undefined. Prostaglandin inhibitors appear to be effective in treating premature labor and have few adverse side effects. CONCLUSIONS: The only tocolytic drugs that might be effective are the prostaglandin inhibitors. Tocolytic agents should be used only between 24 and 32 completed weeks of gestation. Magnesium sulfate should not be used to treat premature labor. Oxytocin antagonists should be used only in experimental clinical trials. Calcium channel blockers and beta-adrenergic receptor agonists inhibit uterine contractions but do not prolong gestation for longer than 48 hours.
引用
收藏
页码:1247 / 1259
页数:13
相关论文
共 48 条
[1]  
Adam G S, 1966, Aust N Z J Obstet Gynaecol, V6, P294, DOI 10.1111/j.1479-828X.1966.tb00392.x
[2]   INHIBITION OF UTERINE CONTRACTIONS OF PREMATURE LABOR WITH AN OXYTOCIN ANALOG - RESULTS FROM A PILOT-STUDY [J].
AKERLUND, M ;
STROMBERG, P ;
HAUKSSON, A ;
ANDERSEN, LF ;
LYNDRUP, J ;
TROJNAR, J ;
MELIN, P .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (11) :1040-1044
[3]   OXYTOCIN RECEPTOR BLOCKADE - A NEW PRINCIPLE IN THE TREATMENT OF PRETERM LABOR [J].
ANDERSEN, LF ;
LYNDRUP, J ;
AKERLUND, M ;
MELIN, P .
AMERICAN JOURNAL OF PERINATOLOGY, 1989, 6 (02) :196-199
[4]   RANDOMIZED COMPARATIVE TRIAL OF INDOMETHACIN AND RITODRINE FOR THE LONG-TERM TREATMENT OF PRETERM LABOR [J].
BESINGER, RE ;
NIEBYL, JR ;
KEYES, WG ;
JOHNSON, TRB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (04) :981-988
[5]  
Calder AA, 1985, PRETERM LABOUR ITS C, P209
[6]   PHARMACOLOGIC INHIBITION OF PRETERM LABOR [J].
CARITIS, SN ;
EDELSTONE, DI ;
MUELLERHEUBACH, E .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 133 (05) :557-578
[7]  
CARLAN SJ, 1992, OBSTET GYNECOL, V79, P223
[8]   TREATMENT OF IMMINENT PREMATURE LABOR - COMPARISON BETWEEN EFFECTS OF NYLIDRIN CHLORIDE AND ISOXUPRINE CHLORIDE AS WELL AS OF ETHANOL [J].
CASTREN, O ;
GUMMERUS, M ;
SAARIKOSKI, S .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1975, 54 (02) :95-100
[9]  
CHRISTENSEN KK, 1980, OBSTET GYNECOL, V55, P187
[10]  
COTTON DB, 1984, J REPROD MED, V29, P92